Press release
Acute Care Syndromic Testing Market Outlook 2025-2034: Key Trends, Growth Drivers, and Market Share
Acute Care Syndromic Testing Market Size
The increasing occurrence of infectious diseases is anticipated to propel the acute care syndromic testing market. Infectious diseases are caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites that can spread between individuals, animals, or the environment. The rising number of infectious diseases is influenced by population growth, urbanization, global travel, antimicrobial resistance, and climate change, intensifying the need for effective disease prevention and treatment. Acute care syndromic testing facilitates rapid identification of pathogens and co-infections using multiplex molecular diagnostics, enabling targeted treatment approaches. For instance, in February 2024, the Health Security Agency, a UK-based government organization, reported that in week 4 of 2024, the influenza positivity rate increased to 16.6%, up from 14.0% the previous week. Influenza-like illness (ILI) consultations also climbed to 9.8 per 100,000 people, compared to 7.5 per 100,000 the prior week. Additionally, influenza-related hospitalizations rose to 7.63 per 100,000, up from 5.12 per 100,000 the previous week. Therefore, the increasing prevalence of infectious diseases is fueling the growth of the acute care syndromic testing market.
Get Your Acute Care Syndromic Testing Market Report Here:
https://www.thebusinessresearchcompany.com/report/acute-care-syndromic-testing-global-market-report
What growth opportunities are expected to drive the acute care syndromic testing market's CAGR through 2034?
The acute care syndromic testing market has expanded rapidly in recent years. It is forecasted to rise from $4.08 billion in 2024 to $4.62 billion in 2025, with a CAGR of 13.2%. The past growth was driven by heightened awareness of antimicrobial resistance, increased government funding for infectious diseases, greater investment in healthcare infrastructure, a growing emphasis on syndromic testing, the expansion of telemedicine, and the rising prevalence of infectious diseases.
The acute care syndromic testing market size is expected to grow rapidly in the coming years. By 2029, it is estimated to reach $7.50 billion at a compound annual growth rate (CAGR) of 12.9%. This growth is driven by the increasing prevalence of infectious diseases, rising demand for faster diagnostic solutions, the expansion of healthcare services, greater use of multiplex syndromic panels, and an aging global population. Key trends forecasted for this period include a shift towards point-of-care testing, integration of cloud-based platforms, adoption of multiplex panels, the development of AI-powered diagnostic tools, and increased automation in syndromic testing.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21078&type=smp
What are the emerging trends shaping the future of the acute care syndromic testing market?
In the acute care syndromic testing market, companies are advancing multiplex real-time PCR technology to enhance diagnostic accuracy and enable rapid pathogen detection. For instance, QIAGEN N.V., a Netherlands-based biotechnology company, launched the QIAstat-Dx syndromic testing solution in April 2023. This system, capable of detecting over 20 pathogens from a single sample, provides rapid results with minimal labor, significantly improving diagnostic efficiency and patient outcomes.
Which growth-oriented segments of the acute care syndromic testing market are leading the industry's development?
The acute care syndromic testing market covered in this report is segmented -
1) By Disease Type: Respiratory Diseases, Gastrointestinal Diseases, Genitourinary Diseases, Tropical Diseases, Other Disease Types
2) By Sample Type: Blood, Urine, Biofluids, Stool, Swabs, Other Sample Types
3) By Target: Bacteria, Viruses, Fungi, Parasites
4) By End User: Hospitals, Clinical And Diagnostic Laboratories, Research And Academic Institutions, Other End Users
Subsegments:
1) By Respiratory Diseases: Influenza, Respiratory Syncytial Virus (RSV), COVID-19, Tuberculosis, Other Respiratory Diseases
2) By Gastrointestinal Diseases: Clostridium Difficile Infection, Norovirus, Rotavirus, Salmonella, Other Gastrointestinal Diseases
3) By Genitourinary Diseases: Urinary Tract Infections (UTIs), Sexually Transmitted Infections (STIs), Vaginal Infections, Other Genitourinary Diseases
4) By Tropical Diseases: Malaria, Dengue, Chikungunya, Zika Virus, Other Tropical Diseases
5) By Other Disease Types: Meningitis, Sepsis, Other Emerging Infectious Diseases
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21078
What regions are leading the charge in the acute care syndromic testing market?
North America was the largest region in the acute care syndromic testing market in 2024. The regions covered in the acute care syndromic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What companies are at the forefront of innovation in the acute care syndromic testing market?
Major companies operating in the acute care syndromic testing market are Siemens Healthineers AG, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Danaher Corporation, Becton, Dickinson and Company, Seegene Inc., bioMérieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Werfen, DiaSorin S.p.A., Quidel Corporation, Luminex Corporation, Biocartis NV, Microbiologics Inc., QuantuMDx Group Ltd., Curetis GmbH by OpGen Inc., Genetic Signatures Ltd., Applied BioCode Inc.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=21078&type=smp
What Is Covered In The Acute Care Syndromic Testing Global Market Report?
•Market Size Forecast: Examine the acute care syndromic testing market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the acute care syndromic testing market for a structured understanding.
•Key Players Overview: Analyze major players in the acute care syndromic testing market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the acute care syndromic testing market.
•Segment Contributions: Evaluate how different segments drive overall growth in the acute care syndromic testing market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the acute care syndromic testing market.
•Industry Challenges: Identify potential risks and obstacles affecting the acute care syndromic testing market.
•Competitive Landscape: Review strategic developments in the acute care syndromic testing market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Acute Care Syndromic Testing Market Outlook 2025-2034: Key Trends, Growth Drivers, and Market Share here
News-ID: 3934530 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
